{
    "2018-03-29": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?",
                "features": {
                    "keywords": [
                        "Geron",
                        "Skyrocketed",
                        "AbbVie",
                        "Crashed"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Analysts’ Ratings for Sorrento and Its Peers in March 2018",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Ratings",
                        "Sorrento",
                        "Peers"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "How AbbVie’s Cash Flows Have Trended",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Cash",
                        "Flows",
                        "Trended"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "What to Expect from AbbVie in 2018",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Expect",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "How Has AbbVie Performed Financially?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Performed",
                        "Financially"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Analyzing AbbVie’s Endocrinology Portfolio",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Endocrinology",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "A Look at AbbVie’s Product Portfolio",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Product",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "What Analysts Recommend for AbbVie and Peers in March 2018",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "AbbVie",
                        "Peers"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "AbbVie Has a Growing Credibility Problem",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Credibility",
                        "Problem"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "How Is Novartis’s Cosentyx Positioned after 4Q17?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "Positioned",
                        "4Q17"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "What Analysts Recommend for Merck in March 2018",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "Merck"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "How Bristol-Myers Squibb’s Virology Drugs Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "Virology",
                        "Drugs",
                        "Performed",
                        "4Q17"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}